| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.23▼ | 2.22▲ | 2.23▲ | 2.17▲ | 2.22▲ |
| MA10 | 2.21▲ | 2.20▲ | 2.18▲ | 2.15▲ | 2.52▼ |
| MA20 | 2.17▲ | 2.16▲ | 2.18▲ | 2.20▲ | 3.11▼ |
| MA50 | 2.20▲ | 2.21▲ | 2.20▲ | 2.51▼ | N/A |
| MA100 | 2.19▲ | 2.28▼ | 2.45▼ | 3.29▼ | N/A |
| MA200 | 2.34▼ | 2.64▼ | 2.64▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.013▲ | 0.015▲ | 0.027▲ | N/A |
| RSI | 55.198▲ | 53.649▲ | 52.776▲ | 47.696▼ | 30.513▼ |
| STOCH | 71.217 | 73.756 | 88.432▲ | 39.720 | 25.807 |
| WILL %R | -24.000▲ | -16.667▲ | -16.216▲ | -24.324▲ | -74.299 |
| CCI | 61.318 | 75.048 | 93.461 | 47.775 | -84.188 |
|
Monday, March 30, 2026 05:20 PM
Vyome Holdings Inc (HIND) showcases promising clinical progress and a robust cash position, despite a significant net loss driven by merger expenses.
|
|
Thursday, March 26, 2026 04:00 AM
Vyome Holdings, Inc., (“Vyome”) (Nasdaq: HIND), a next-generation inflammation-focused company leveraging the US-India innovation corridor, today announced its financial results and corporate and ...
|
|
Monday, January 26, 2026 04:00 PM
Company Chose Minimal Dilution Path with No Warrants and Has Sufficient Liquidity to Deliver Initial Phase 3 Results for MFW product CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vyome Holdings, Inc. (“Vyome” ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/04/26 | 2.14 | 2.34 | 2.07 | 2.30 | 15,926 |
| 08/04/26 | 2.1947 | 2.2499 | 2.13 | 2.13 | 12,007 |
| 07/04/26 | 2.13 | 2.36 | 2.02 | 2.11 | 18,339 |
| 06/04/26 | 2.15 | 2.2551 | 2.15 | 2.16 | 12,033 |
| 02/04/26 | 2.2057 | 2.2099 | 2.12 | 2.13 | 5,145 |
| 01/04/26 | 2.15 | 2.22 | 2.12 | 2.15 | 11,653 |
| 31/03/26 | 2.1199 | 2.23 | 2.08 | 2.15 | 25,820 |
| 30/03/26 | 2.0853 | 2.15 | 2.04 | 2.04 | 21,685 |
| 27/03/26 | 2.15 | 2.19 | 2.11 | 2.13 | 35,498 |
| 26/03/26 | 2.2525 | 2.2914 | 2.20 | 2.20 | 6,717 |
|
|
||||
|
|
||||
|
|